Testosterone re- placement therapy and prostate cancer: a word of caution. Curr Urol Rep. 2007;8:185-9.Brand TC, Canby-Hagino E, Thompson IM. Testosterone replacement therapy and prostate cancer: a word of caution. Curr Urol Rep 2007;8:185-9....
Barqawi A, Crawford ED (2006) Testosterone replacement therapy and the risk of prostate cancer. Is there a link? Int J Impot Res 18(4): 323-328.Barqawi, A. B.; Crawford, E. D. Testosterone replacement therapy and the risk of prostate cancer: a perspective view. Int. J. Impotence ...
INTRODUCTION AND OBJECTIVES Given that some cancers are androgen dependent, there is concern that testosterone replacement therapy will increase a man's risk of developing cancer. To date there are no long term, prospective studies which evaluate the incidence of cancer in men on testosterone ...
Testosterone replacement therapy and the risk of prostate cancer in men with late-onset hypogonadism. Am J Epidemiol. 2019;188:1666–73. Article Google Scholar Cook MB, Beachler DC, Parlett LE, Cochetti PT, Finkle WD, Lanes S, et al. Testosterone therapy in relation to prostate cancer ...
With an increasing prevalence of testosterone deficiency and diabetes in older men, metformin and testosterone replacement therapy are increasingly used in combination. Metformin has been previously linked with a reduction in overall cancer risk; however, the effects of the drug combined with testosterone...
Re: Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer DF Penson - 《Journal of Urology》 被引量: 0发表: 2018年 Leptin is associated with increased prostate cancer risk: a nested case-referent study. A Western lifestyle has been implicated in the pathogenesis ...
This phase IV trial studies the effects of testosterone replacement therapy (TRT) on treatment outcomes in hypogonadal men with prostate cancer that has not spread to other parts of the body (localized) and who are on active surveillance (AS). AS in prostate cancer involves closely watching the...
(2005), Testosterone replacement therapy in hypogonadal men and prostate cancer risk. BJU International, 96: 471–472. doi: 10.1111/j.1464-410X.2005.05665.x Author Information Department of Urology, St George's Hospital, London, UK *Duncan Gould, 20 Harmont House, 20 Harley Street, London, ...
Testosterone replacement therapy (TRT) for cancer survivors and advanced cancer patients is not well studied outside of prostate cancer. Here, we evaluate and summarize the current literature on HG in male cancer patients, including the role of TRT in nonprostate cancer patients.Perry Xu MD...
To explore the practice and attitudes of uro-oncologists in the UK regarding monitoring testosterone levels and the use of testosterone replacement therapy (TRT) in their prostate cancer patients treated with androgen deprivation therapy (ADT).An expert-devised online questionnaire was completed by memb...